University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
迈阿密大学儿科围产期艾滋病毒/艾滋病临床试验单位
基本信息
- 批准号:7571640
- 负责人:
- 金额:$ 84.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-02-15 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAdolescentAdolescent MedicineAreaCaringChildChildhoodClinicalClinical ManagementClinical ResearchClinical TrialsClinical Trials UnitCollaborationsCommunitiesConduct Clinical TrialsCountyDiscipline of obstetricsDrug CombinationsFacultyFutureHIVHIV InfectionsIMPAACTImmuneIndividualInfantInternationalInterventionLaboratoriesMinorityMorbidity - disease rateMothersPediatricsPerinatalPharmaceutical PreparationsPopulationPregnant WomenPreventionPrincipal InvestigatorRecording of previous eventsResearchResearch ActivityResearch PersonnelSiteStudy SubjectTranslational ResearchUniversitiesVaccinesVertical Disease TransmissionWomanbaseclinical research sitedata managementdrug developmentmemberoutreachprogramstransmission process
项目摘要
DESCRIPTION (provided by applicant): This application entitled "University of Miami Pediatric /Perinatal HIV/AIDS Clinical Trial 5 Unit" proposes a Clinical Trials Unit made up of an Administrative Core and a Clinical Research Site aligned with the IMPAACT Network with Dr. Gwendolyn Scott as the Principal Investigator and Dr. Chares Mitchell as the Site Leader. This is a collaboration between Pediatrics, Obstetrics and Adolescent Medicine to provide access to clinical trials for HIV infected pregnant women, infants, children and youth. Tie CTU investigators have a distinguished past record of accomplishments in HIV/AIDS clinical trials over the past 17 years. In particular, this site has made significant contributions to the reduction of HIV perinatal transmission in the US. The scientific priorities of the proposed CTU are as follows: 1. Prevention of Mother to Infant Transmission, 2. Translational Research/Drug Development, 3. Optimization of Clinical Management, Including Co-Morbidities, and 4. Vaccines. The focus of the clinical research activities proposed is primarily domestic. Miami-Dade County has a large population of HIV infected women and children and many of the infected individuals are members of minority populations. Many of these infected children, youth and pregnant women receive care at the University of Miami (UM). We will be able to comply with the requirements of the minimum 20/month average case load. The strengths of the UM Podiatric/Perinatal IMPAACT Unit are: 1. the expertise of the faculty and their record in conducting clinical trials since 1987, 2. the past and potential future scientific contributions of the investigators, 3. the strong collaboration between Pediatrics, Obstetrics and Adolescent Medicine, 4. good retention of study subjects, 5. an exemplar/ record in data management, 6. a large population of potential study subjects in all three areas; children, adolescents, and pregnant women, 7. excellent laboratory support, 8. outreach efforts which integrate with community programs, and 9. a long history of international collaborative research initiatives. This application will provide access to new drugs and drug combinations, immune based therapies, such as vaccines and other interventions for treating infants, children, adolescents and pregnant women with HIV infection. It will also provide further research on preventative strategies, such as vaccines and medications to reduce mother to child transmission both in the US and internationally.
ADMINISTRATIVE COMPONENT:
描述(由申请人提供):本申请标题为“迈阿密大学儿科/围产期HIV/AIDS临床试验5单元”,提出了一个临床试验单元,由一个管理核心和一个与IMPAACT网络一致的临床研究中心组成,Gwendolyn Scott博士为主要研究者,Chares Mitchell博士为中心负责人。这是儿科、产科和青少年医学之间的合作,为感染艾滋病毒的孕妇、婴儿、儿童和青年提供临床试验。Tie CTU研究人员在过去17年中在艾滋病毒/艾滋病临床试验方面取得了杰出的成就。特别是,该网站为减少美国艾滋病毒围产期传播做出了重大贡献。建议CTU的科学优先事项如下:1。预防母婴传播,2。转化研究/药物开发,3。优化临床管理,包括合并症,和4。疫苗建议的临床研究活动的重点主要是国内。迈阿密-戴德县有大量感染艾滋病毒的妇女和儿童,许多感染者是少数民族人口。许多受感染的儿童、青年和孕妇在迈阿密大学(UM)接受护理。我们将能够遵守最低20/月平均案件负载的要求。UM足科/围产期IMPAACT单位的优势是:1。教师的专业知识和他们的记录进行临床试验自1987年以来,2。研究人员过去和未来可能的科学贡献,3。儿科,产科和青少年医学之间的密切合作,4。良好的保持学习对象,5。数据管理中的范例/记录,6.在所有三个领域的大量潜在研究对象;儿童,青少年和孕妇,7。优秀的实验室支持,8。与社区计划相结合的外展工作,以及9.国际合作研究倡议的悠久历史。这一应用将使人们有机会获得新的药物和药物组合、免疫疗法,如疫苗和其他干预措施,以治疗感染艾滋病毒的婴儿、儿童、青少年和孕妇。它还将进一步研究预防策略,如疫苗和药物,以减少美国和国际上的母婴传播。
行政部门:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GWENDOLYN Barbara SCOTT其他文献
GWENDOLYN Barbara SCOTT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GWENDOLYN Barbara SCOTT', 18)}}的其他基金
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
迈阿密大学儿科围产期艾滋病毒/艾滋病临床试验单位
- 批准号:
7096148 - 财政年份:2007
- 资助金额:
$ 84.83万 - 项目类别:
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
迈阿密大学儿科围产期艾滋病毒/艾滋病临床试验单位
- 批准号:
7356001 - 财政年份:2007
- 资助金额:
$ 84.83万 - 项目类别:
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
迈阿密大学儿科围产期艾滋病毒/艾滋病临床试验单位
- 批准号:
7743589 - 财政年份:2007
- 资助金额:
$ 84.83万 - 项目类别:
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
迈阿密大学儿科围产期艾滋病毒/艾滋病临床试验单位
- 批准号:
8197766 - 财政年份:2007
- 资助金额:
$ 84.83万 - 项目类别:
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
迈阿密大学儿科围产期艾滋病毒/艾滋病临床试验单位
- 批准号:
8402109 - 财政年份:2007
- 资助金额:
$ 84.83万 - 项目类别:
相似海外基金
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 84.83万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 84.83万 - 项目类别:
Children's Hospital Los Angeles Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
洛杉矶儿童医院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709604 - 财政年份:2022
- 资助金额:
$ 84.83万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709602 - 财政年份:2022
- 资助金额:
$ 84.83万 - 项目类别:
The Hektoen Institute of Medical Research Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
Hektoen 医学研究所站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709606 - 财政年份:2022
- 资助金额:
$ 84.83万 - 项目类别:
Children's National Hospital Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
国家儿童医院基地联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599559 - 财政年份:2022
- 资助金额:
$ 84.83万 - 项目类别:
University of South Florida Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
南佛罗里达大学站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709612 - 财政年份:2022
- 资助金额:
$ 84.83万 - 项目类别:
Johns Hopkins University Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
约翰·霍普金斯大学站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709609 - 财政年份:2022
- 资助金额:
$ 84.83万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599556 - 财政年份:2022
- 资助金额:
$ 84.83万 - 项目类别:
Children's Hospital Los Angeles Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
洛杉矶儿童医院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599558 - 财政年份:2022
- 资助金额:
$ 84.83万 - 项目类别: